Indoleamine 2,3-Dioxygenase: Expressing Cells in Inflammatory Bowel Disease—A Cross-Sectional Study

Figure 1

Density plots of cytokine-expressing CD4⁺ T peripheral cells in IBD (UC and CD) patients. (a) CD14⁻/CD4⁺ T cells were determined. (b) From the latter CD14⁻/CD4⁺/IL-17A⁺ cells were defined. (c) From the gate 𝐴 CD14⁻/CD4⁺/IL-4⁺ cells were determined. (d) From the gate 𝐴 CD14⁻/CD4⁺/IFN-γ ⁺ cells were defined. (e) From the gate 𝐴 CD14⁻/CD4⁺/IL-10⁺ cells were determined. (f) CD4⁺/CD25^hi/Foxp3⁺ cells were defined. A total of 50,000–100,000 events were recorded for each sample before any gate setting and analysed with the CellQuest Pro software (BD Biosciences).

(a)

(b)

(c)

(d)

(e)

(f)